Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.

Gregory KuchcinskiEmilie Le RhunAlexis B CortotElodie DrumezRomain DuhalMaxime LalisseJulien DumontRenaud LopesJean-Pierre PruvoXavier LeclercChristine Delmaire

Published in: European radiology (2017)

• DCE MRI could predict the response of brain metastases from lung cancer • ∆v e was the best predictor of response • DCE MRI could be used to individualize patients' follow-up.

Keyphrases

brain metastases
contrast enhanced
small cell lung cancer
magnetic resonance imaging
magnetic resonance
end stage renal disease
computed tomography
ejection fraction
newly diagnosed
diffusion weighted imaging
prognostic factors